Literature DB >> 9973466

Identification of tyrosine phosphorylation sites in the CD28 cytoplasmic domain and their role in the costimulation of Jurkat T cells.

A Sadra1, T Cinek, J L Arellano, J Shi, K E Truitt, J B Imboden.   

Abstract

The cytoplasmic domain of CD28 contains four tyrosine residues. Because signal transduction by CD28 appears to involve its tyrosine phosphorylation, we determined sites of CD28 tyrosine phosphorylation using mutants of mouse CD28 that retained tyrosine at one position, with the remaining three positions mutated to phenylalanine. When expressed in Jurkat cells and stimulated by mAb, only the mutants with tyrosine at position 170 or 188 were tyrosine phosphorylated. Phosphorylation of Tyr170 recruits phosphatidylinositol 3-kinase to CD28. Tyr188 has not been associated with any specific signaling event, but we found that ligation of CD28 by the natural ligand B7.2 also induced phosphorylation of Tyr188, suggesting that this event is of physiological importance. Consistent with that possibility, mutation of Tyr188 to phenylalanine severely impaired the ability of mouse CD28 to deliver a costimulus for the expression of CD69 and the production of IL-2. The functional consequences of the mutation of Tyr188 were unique; mutation of the other three tyrosines, individually or in combination, did not impair costimulation. Therefore, of the four CD28 tyrosine residues only Tyr188 is required for signaling in Jurkat cells, suggesting that its phosphorylation is a key event in the costimulation of T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973466

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Genetic analysis of CD28 signaling.

Authors:  Tiffani A Greene; Virginia Smith Shapiro
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 2.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

3.  Vav1 Regulates T-Cell Activation through a Feedback Mechanism and Crosstalk between the T-Cell Receptor and CD28.

Authors:  Ynes A Helou; Anna P Petrashen; Arthur R Salomon
Journal:  J Proteome Res       Date:  2015-06-16       Impact factor: 4.466

Review 4.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

5.  Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling.

Authors:  Jessica Dobbins; Etienne Gagnon; Jernej Godec; Jason Pyrdol; Dario A A Vignali; Arlene H Sharpe; Kai W Wucherpfennig
Journal:  Sci Signal       Date:  2016-07-26       Impact factor: 8.192

6.  Translocation of CD28 to lipid rafts and costimulation of IL-2.

Authors:  Ali Sadra; Tomas Cinek; John B Imboden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

7.  Signals and sequences that control CD28 localization to the central region of the immunological synapse.

Authors:  Mariano Sanchez-Lockhart; Beth Graf; Jim Miller
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

8.  PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors.

Authors:  Noah Isakov; Amnon Altman
Journal:  Front Immunol       Date:  2012-08-22       Impact factor: 7.561

9.  A motif in the V3 domain of the kinase PKC-θ determines its localization in the immunological synapse and functions in T cells via association with CD28.

Authors:  Kok-Fai Kong; Tadashi Yokosuka; Ann J Canonigo-Balancio; Noah Isakov; Takashi Saito; Amnon Altman
Journal:  Nat Immunol       Date:  2011-10-02       Impact factor: 25.606

10.  Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro.

Authors:  Anthony Simmons; Robert P Whitehead; Andrey A Kolokoltsov; Robert A Davey
Journal:  Virol J       Date:  2006-02-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.